Search Results - "Gagea, Mihai"

Refine Results
  1. 1
  2. 2

    KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis by Wei, Daoyan, Wang, Liang, Yan, Yongmin, Jia, Zhiliang, Gagea, Mihai, Li, Zhiwei, Zuo, Xiangsheng, Kong, Xiangyu, Huang, Suyun, Xie, Keping

    Published in Cancer cell (14-03-2016)
    “…Understanding the molecular mechanisms of tumor initiation has significant impact on early cancer detection and intervention. To define the role of KLF4 in…”
    Get full text
    Journal Article
  3. 3

    YAP/TAZ-Mediated Upregulation of GAB2 Leads to Increased Sensitivity to Growth Factor-Induced Activation of the PI3K Pathway by Wang, Chao, Gu, Chao, Jeong, Kang Jin, Zhang, Dong, Guo, Wei, Lu, Yiling, Ju, Zhenlin, Panupinthu, Nattapon, Yang, Ji Yeon, Gagea, Mihai Mike, Ng, Patrick Kwok Shing, Zhang, Fan, Mills, Gordon B

    Published in Cancer research (Chicago, Ill.) (01-04-2017)
    “…The transcription regulators YAP and TAZ function as effectors of the HIPPO signaling cascade, critical for organismal development, cell growth, and cellular…”
    Get full text
    Journal Article
  4. 4

    Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice by Jung, Kwang Hwa, Yoo, Wonbeak, Stevenson, Heather L, Deshpande, Dipti, Shen, Hong, Gagea, Mihai, Yoo, Suk-Young, Wang, Jing, Eckols, T Kris, Bharadwaj, Uddalak, Tweardy, David J, Beretta, Laura

    Published in Clinical cancer research (15-09-2017)
    “…The incidence of hepatocellular carcinoma is increasing in the United States, and liver cancer is the second leading cause of cancer-related mortality…”
    Get full text
    Journal Article
  5. 5

    Generation and testing of clinical-grade exosomes for pancreatic cancer by Mendt, Mayela, Kamerkar, Sushrut, Sugimoto, Hikaru, McAndrews, Kathleen M, Wu, Chia-Chin, Gagea, Mihai, Yang, Sujuan, Blanko, Elena V Rodriges, Peng, Qian, Ma, Xiaoyan, Marszalek, Joseph R, Maitra, Anirban, Yee, Cassian, Rezvani, Katayoun, Shpall, Elizabeth, LeBleu, Valerie S, Kalluri, Raghu

    Published in JCI insight (19-04-2018)
    “…Exosomes are extracellular vesicles produced by all cells with a remarkable ability to efficiently transfer genetic material, including exogenously loaded…”
    Get full text
    Journal Article
  6. 6
  7. 7

    IL‐30 (IL27p28) attenuates liver fibrosis through inducing NKG2D‐rae1 interaction between NKT and activated hepatic stellate cells in mice by Mitra, Abhisek, Satelli, Arun, Yan, Jun, Xueqing, Xia, Gagea, Mihai, Hunter, Christopher A., Mishra, Lopa, Li, Shulin

    Published in Hepatology (Baltimore, Md.) (01-12-2014)
    “…Chronic hepatic diseases, such as cirrhosis, hepatocellular carcinoma, and virus‐mediated immunopathogenic infections, affect billions of people worldwide…”
    Get full text
    Journal Article
  8. 8
  9. 9

    YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer by Mi, Wenyi, Guan, Haipeng, Lyu, Jie, Zhao, Dan, Xi, Yuanxin, Jiang, Shiming, Andrews, Forest H., Wang, Xiaolu, Gagea, Mihai, Wen, Hong, Tora, Laszlo, Dent, Sharon Y. R., Kutateladze, Tatiana G., Li, Wei, Li, Haitao, Shi, Xiaobing

    Published in Nature communications (20-10-2017)
    “…Recognition of modified histones by “reader” proteins constitutes a key mechanism regulating diverse chromatin-associated processes important for normal and…”
    Get full text
    Journal Article
  10. 10

    Differentiation therapy for hepatocellular carcinoma: Multifaceted effects of miR‐148a on tumor growth and phenotype and liver fibrosis by Jung, Kwang Hwa, Zhang, Jing, Zhou, Chong, Shen, Hong, Gagea, Mihai, Rodriguez‐Aguayo, Cristian, Lopez‐Berestein, Gabriel, Sood, Anil K., Beretta, Laura

    Published in Hepatology (Baltimore, Md.) (01-03-2016)
    “…The death rate from hepatocellular carcinoma (HCC) is increasing, and liver cancer is the second leading cause of cancer‐related mortality worldwide. Most…”
    Get full text
    Journal Article
  11. 11

    miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells by Zhang, Jing, Jiao, Jingjing, Cermelli, Silvia, Muir, Kyle, Jung, Kwang Hwa, Zou, Ruhai, Rashid, Asif, Gagea, Mihai, Zabludoff, Sonya, Kalluri, Raghu, Beretta, Laura

    Published in Cancer research (Chicago, Ill.) (01-05-2015)
    “…miR-21 is upregulated in hepatocellular carcinoma and intrahepatic cholangiocarcinoma, where it is associated with poor prognosis. Here, we offer preclinical…”
    Get full text
    Journal Article
  12. 12

    A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53 by Dibra, Denada, Xia, Xueqing, Gagea, Mihai, Lozano, Guillermina, Li, Shulin

    Published in PloS one (01-03-2018)
    “…Spondyloarthropathies, the second most frequently occurring form of chronic inflammatory arthritis, affects young adults in particular. However, a proper model…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia by Aslan, Burcu, Kismali, Gorkem, Iles, Lakesla R., Manyam, Ganiraju C., Ayres, Mary L., Chen, Lisa S., Gagea, Mihai, Bertilaccio, Maria Teresa Sabrina, Wierda, William G., Gandhi, Varsha

    Published in Blood cancer journal (New York) (20-05-2022)
    “…Pirtobrutinib (LOXO-305), a reversible inhibitor of Bruton’s tyrosine kinase (BTK), was designed as an alternative strategy to treat ibrutinib-resistant…”
    Get full text
    Journal Article
  15. 15

    NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway–Driven Intestinal Neoplasia by Georgescu, Maria-Magdalena, Gagea, Mihai, Cote, Gilbert

    Published in Neoplasia (New York, N.Y.) (01-08-2016)
    “…Abstract NHERF1/EBP50, an adaptor molecule that interacts with β-catenin, YAP, and PTEN, has been recently implicated in the progression of various human…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Grb2 monomer–dimer equilibrium determines normal versus oncogenic function by Ahmed, Zamal, Timsah, Zahra, Suen, Kin M., Cook, Nathan P., Lee, Gilbert R., Lin, Chi-Chuan, Gagea, Mihai, Marti, Angel A., Ladbury, John E.

    Published in Nature communications (24-06-2015)
    “…The adaptor protein growth factor receptor-bound protein 2 (Grb2) is ubiquitously expressed in eukaryotic cells and involved in a multitude of intracellular…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Sulindac plus a phospholipid is effective for polyp reduction and safer than sulindac alone in a mouse model of colorectal cancer development by Davis, Jennifer S, Kanikarla-Marie, Preeti, Gagea, Mihai, Yu, Patrick L, Fang, Dexing, Sebastian, Manu, Yang, Peiying, Hawk, Ernest, Dashwood, Roderick, Lichtenberger, Lenard M, Menter, David, Kopetz, Scott

    Published in BMC cancer (10-09-2020)
    “…Non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin and sulindac are effective for colorectal cancer prevention in humans and some animal models,…”
    Get full text
    Journal Article
  20. 20

    Human Biofield Therapy and the Growth of Mouse Lung Carcinoma by Yang, Peiying, Jiang, Yan, Rhea, Patrea R., Conway, Tara L., Chen, Dongmei, Gagea, Mihai, Harribance, Sean L., Cohen, Lorenzo

    Published in Integrative cancer therapies (01-01-2019)
    “…Biofield therapies have gained popularity and are being explored as possible treatments for cancer. In some cases, devices have been developed that mimic the…”
    Get full text
    Journal Article